Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2025-12-30 @ 4:09 AM
Study NCT ID:
NCT01013961
Status:
TERMINATED
Last Update Posted:
2023-06-28
First Post:
2009-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04-14
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-13
First Submit QC Date:
None
Study First Post Date:
2009-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-22
Results First Submit QC Date:
None
Results First Post Date:
2016-01-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-13
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL